Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
RESEARCH TOOLSreports
Holding AU:ACL?
Track your performance easily
ACL Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$2.14 - AU$3.86
Previous CloseAU$3.5
Volume953.69K
Average Volume (3M)2.37M
Market Cap
AU$702.64M
Enterprise ValueAU$940.94M
Total Cash (Recent Filing)AU$26.37M
Total Debt (Recent Filing)AU$262.38M
Price to Earnings (P/E)29.1
Beta0.63
Next Earnings
Feb 19, 2025EPS Estimate
AU$0.08Last Dividend Ex-Date
Sep 04, 2024Dividend Yield3.43%
Share Statistics
EPS (TTM)0.12
Shares OutstandingN/A
10 Day Avg. Volume807,306
30 Day Avg. Volume2,373,693
Standard Deviation0.13
R-Squared0.20
Alpha0.00218
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$4.10Price Target Upside15.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Australian Clinical Labs Ltd News
PremiumCompany Announcements
Australian Clinical Labs Updates Share Buy-Back Program
PremiumCompany Announcements
Australian Clinical Labs Sees Change in Major Holders
PremiumCompany Announcements
Commonwealth Bank Adjusts Holdings in Australian Clinical Labs
PremiumCompany Announcements
Australian Clinical Labs Optimizes Capital with Buy-Back
PremiumCompany Announcements
Australian Clinical Labs Updates Share Buy-Back ProgramPremiumCompany Announcements
Australian Clinical Labs Announces Ongoing Share Buy-Back
PremiumCompany Announcements
UBS Group AG Acquires Significant Stake in Australian Clinical Labs
PremiumCompany Announcements
Australian Clinical Labs Sees Change in Shareholder InterestsOptions Prices
Currently, No data available
---
Ownership Overview
<0.01% Insiders
1.99% Mutual Funds
― Other Institutional Investors
96.40% Public Companies and
Individual Investors
ACL FAQ
What was Australian Clinical Labs Ltd’s price range in the past 12 months?
Australian Clinical Labs Ltd lowest share price was AU$2.14 and its highest was AU$3.85 in the past 12 months.
What is Australian Clinical Labs Ltd’s market cap?
Currently, no data Available
When is Australian Clinical Labs Ltd’s upcoming earnings report date?
Australian Clinical Labs Ltd’s upcoming earnings report date is Feb 19, 2025 which is in 85 days.
How were Australian Clinical Labs Ltd’s earnings last quarter?
Australian Clinical Labs Ltd released its earnings results on Aug 29, 2024. The company reported AU$0.107 earnings per share for the quarter, beating the consensus estimate of AU$0.08 by AU$0.027.
Is Australian Clinical Labs Ltd overvalued?
According to Wall Street analysts Australian Clinical Labs Ltd’s price is currently Undervalued.
Does Australian Clinical Labs Ltd pay dividends?
Australian Clinical Labs Ltd pays a Annually dividend of AU$0.09 which represents an annual dividend yield of 3.43%. See more information on Australian Clinical Labs Ltd dividends here
What is Australian Clinical Labs Ltd’s EPS estimate?
Australian Clinical Labs Ltd’s EPS estimate is AU$0.08.
How many shares outstanding does Australian Clinical Labs Ltd have?
Australian Clinical Labs Ltd has 201,378,170 shares outstanding.
What happened to Australian Clinical Labs Ltd’s price movement after its last earnings report?
Australian Clinical Labs Ltd reported an EPS of AU$0.107 in its last earnings report, beating expectations of AU$0.08. Following the earnings report the stock price went up 9.266%.
Which hedge fund is a major shareholder of Australian Clinical Labs Ltd?
Currently, no hedge funds are holding shares in AU:ACL
---
Australian Clinical Labs Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$4.10 (15.49% Upside)
AU$4.10 (15.49% Upside)
Blogger Sentiment
Bullish
AU:ACL Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
13.68%
Trailing 12-Months
Asset Growth
2.44%
Trailing 12-Months
Company Description
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd is engaged in the provision of pathology services. Its services include all routine pathology tests, advanced pathology, First-trimester screening, and Non-Invasive prenatal testing, Chemical pathology, Haematology, Histopathology, Immunology, Serology and microbiology, Functional pathology, Commercial drug, and alcohol testing. The company has its operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
---
ACL Stock 12 Month Forecast
Average Price Target
AU$4.10
▲(15.49% Upside)
Technical Analysis
Sonic Healthcare Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Monash IVF Group Ltd
―
Capitol Health Limited
―
Best Analysts Covering ACL
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-2.50%
reiterated a buy rating 3 months ago
Copying Mathieu Chevrier's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -2.50% per trade.
---